Ocumension Therapeutics
Director at EYPT
- Sold, on record
- $56.7M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Jan 11, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- EYPTEyePoint, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice EYPTNoticeMay 26, 2023 2023
Filed to sell 3M shares ($17.9M)
Ocumension Therapeutics, Director
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 notice EYPTNoticeDec 5, 2023 +193 days
Filed to sell 1M shares ($18.3M)
Ocumension Therapeutics, Director
No 10b5-1 planFirst sale on recordFiling
- 3 Form 4 sale EYPTUnusualDec 6, 2023 +1 day
Sold 1M shares at $19.51 ($19.5M)
Ocumension Therapeutics, Director
No 10b5-1 planSold 33.2% of holdings ($58.7M position)2M shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice EYPTNoticeJan 11, 2024 +36 days
Filed to sell 1.9M shares ($37.2M)
Ocumension Therapeutics, Director
No 10b5-1 planFiling
- 5 Form 4 sale EYPTUnusualJan 11, 2024 same day
Sold 1.9M shares at $19.45 ($37.2M)
Ocumension Therapeutics, Director
No 10b5-1 planSold 95% of holdings ($39.1M position)100,221 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 11, 2024 | Jan 16, 2024 | EYPT | Director | Form 4 sale | 1.9M | $37.2M | 95.0% | Unusual | SEC |
| Jan 11, 2024 | Jan 11, 2024 | EYPT | Director | Form 144 notice | 1.9M | $37.2M | Notice | SEC | |
| Dec 6, 2023 | Dec 7, 2023 | EYPT | Director | Form 4 sale | 1M | $19.5M | 33.2% | Unusual | SEC |
| Dec 5, 2023 | Dec 5, 2023 | EYPT | Director | Form 144 notice | 1M | $18.3M | Notice | SEC | |
| May 26, 2023 | May 26, 2023 | EYPT | Director | Form 144 notice | 3M | $17.9M | Notice | SEC |